, Singapore
115 views
Photo from Singapore Airlines

SIA in talks with Tata Group over potential integration of Vistara and Air India

The airline holds a 49% stake in Vistara's operator.

Singapore Airlines Limited (SIA) is in discussion with Tata Group to integrate the latter's subsidiary, Air India, with Vistara, where both companies have a major stake.

Tata Group has a 51% equity interest in Vistara, whilst SIA holds a 49% stake in the airline's operator, SIA Tata Airlines Limited.

"SIA is currently in confidential discussions with Tata to explore a potential transaction in relation to the securities of Vistara and Air India," the airline said in a bourse filing.

"The discussions are ongoing, and no definitive terms have been agreed upon between the parties. There is no certainty or assurance that any definitive agreement will be entered into or the potential transaction will materialize or proceed to completion arising from these discussions," SIA added. 

Follow the link for more news on

Join Singapore Business Review community
Since you're here...

...there are many ways you can work with us to advertise your company and connect to your customers. Our team can help you dight and create an advertising campaign, in print and digital, on this website and in print magazine.

We can also organize a real life or digital event for you and find thought leader speakers as well as industry leaders, who could be your potential partners, to join the event. We also run some awards programmes which give you an opportunity to be recognized for your achievements during the year and you can join this as a participant or a sponsor.

Let us help you drive your business forward with a good partnership!

Top News

DBS and OCBC expected to deliver steady Q1 net profits
Their net interest margins will ease as a result of their Hong Kong loans.
Singapore's maritime cluster navigates towards digital, green future
Adapting to emerging challenges, such as the adoption of alternative fuels, is deemed crucial for the country's maritime sector.
SCG and A*STAR unveil joint labs for cellular immunotherapy enhancement
The partnership has a funding of nearly $30m supported under Singapore's Research, Innovation and Enterprise 2025 plan.
Healthcare